WHO Conference: Seroprevalence and vaccines
Share - WeChat
On Monday, the Director General of the World Health Organization Tedros Adhanom Ghebreyesus said seroprevalence studies are vital in understanding vaccine can last.
Most Viewed in 24 Hours